Whan In Pharm Co.,Ltd. (KRX:016580)
11,900
-80 (-0.67%)
Last updated: Jun 23, 2025
Whan In Pharm Revenue
Whan In Pharm had revenue of 60.20B KRW in the quarter ending March 31, 2025, a decrease of -2.29%. This brings the company's revenue in the last twelve months to 258.19B, up 9.19% year-over-year. In the year 2024, Whan In Pharm had annual revenue of 259.60B with 12.68% growth.
Revenue (ttm)
258.19B
Revenue Growth
+9.19%
P/S Ratio
0.70
Revenue / Employee
422.56M
Employees
611
Market Cap
180.76B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 259.60B | 29.20B | 12.68% |
Dec 31, 2023 | 230.39B | 31.46B | 15.81% |
Dec 31, 2022 | 198.93B | 21.16B | 11.90% |
Dec 31, 2021 | 177.78B | 6.07B | 3.54% |
Dec 31, 2020 | 171.71B | 12.53B | 7.87% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2012 | Pro | Pro | Pro |
Dec 31, 2011 | Pro | Pro | Pro |
Dec 31, 2010 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
Peptron | 4.30B |